People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Interius BioTherapeutics, Inc. | — | Biotechnology | Series C | $118.1M | $478.4M | 2020 |
| Windtree Therapeutics Inc /De/ | — | Biotechnology | Series B | $104.5M | $1.0B | 2019 |
| CARISMA Therapeutics Inc. | — | Biotechnology | Series C | $95.0M | $1.3B | 2017 |
| PanOptica, Inc. | — | Biotechnology | Series C | $57.3M | $1.7B | 2014 |
| ViTToria Biotherapeutics, Inc. | — | Biotechnology | Series A | $8.7M | $187.9M | 2021 |
Bruce Peacock at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Peacock on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Briggs Morrison | 1 | 8 |
| David Guyer | 1 | 8 |
| Geeta Vemuri | 1 | 7 |
| Lutz Giebel | 1 | 6 |
| Daniel Geffken | 1 | 6 |
| Leon O. Moulder, Jr. | 1 | 6 |
| ABBIE CELNIKER | 1 | 6 |
| Michael Heffernan | 1 | 5 |
| Tracy Saxton | 1 | 5 |
| Kevin Starr | 1 | 5 |
| Colin Goddard | 1 | 5 |
| James Huang | 1 | 5 |
| Thomas Dyrberg | 1 | 5 |
| Steven Kelly | 1 | 4 |
| Margarita Chavez | 1 | 4 |
| Michael Poisel | 1 | 4 |
| Eran Nadav | 1 | 4 |
| Leon Moulder | 1 | 3 |
| Joseph M. Mahady | 1 | 3 |
| W. Thomas Amick | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.